FOLH1 and prostate carcinoma: PSMA is a type II transmembrane glycoprotein encoded by the FOLH1 (Folate hydrolase) gene and was first found as the target for monoclonal antibody 7EII-C5.3 in a preclinical study with prostate cancer cell lines.